The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Stephen W. Fesik |
| Publication date | January 23, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |